SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN’S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA

Gerassimos J. Mantzaris  1     Andres Yarur  2     Song Wang  3     Shashi Adsul  4     Pravin Kamble  5     Michelle Luo  6     Annie Guerin  7     Emma Billmyer  7     Ha Nguyen  7     Brian Bressler  8    
1 Evangelismos Hospital, Athens, Greece
2 Medical College of Wisconsin, Milwaukee, United States
3 Takeda Pharmaceuticals International Co., Cambridge, United States
4 Takeda, Zurich, Switzerland
5 Takeda Pharmaceuticals Inc., Cambridge, United States
6 Takeda, Cambridge, United States
7 Analysis Group, Boston, United States
8 University of British Columbia, Vancouver, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing